Volume 36 Issue 3
May  2020
Turn off MathJax
Article Contents
ZOUXiao-yan, FANXiang-cheng, TIANYou-qing, SHANGJing. Effects of Luteolin and Its Analogues Against Myocardial Ischemia/Reperfusion Injury, Lipid Metabolism and Apoptosis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(3): 380-386.
Citation: ZOUXiao-yan, FANXiang-cheng, TIANYou-qing, SHANGJing. Effects of Luteolin and Its Analogues Against Myocardial Ischemia/Reperfusion Injury, Lipid Metabolism and Apoptosis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(3): 380-386.

Effects of Luteolin and Its Analogues Against Myocardial Ischemia/Reperfusion Injury, Lipid Metabolism and Apoptosis

  • Publish Date: 2020-05-10
  • OBJECTIVE To explore the multi-component and on MIRI model rat multi-target mechanism of Chinese medicine against MIRI, the protective effects of luteolin, kaempferol and luteoloside on rat MIRI, and the inhibition on lipid-metabolization-related enzymes 11β-HSD1, LPAATβ, and apoptosis-related enzymes PTEN, and SHP-2. METHEODS Using a Langendorff apparatus, the MIRI model was established by stopping perfusion and reperfusion with oxygenated Locke-Ringer's solution. The HR, LVEDP, LVDP, (-dp/dt)/(+dp/dt), CF, LDH and myocardial infarct size were assayed. LPAATβ and 11β-HSD1 were assayed by spectrophotometry. The inhibition of PTEN and SHP-2 activity was measured by spectrophotometry. RESULTS Luteolin, kaempferol and luteoloside could protect HR, reduce LDH release, raise LVDP, LVEDP and (-dp/dt)/ (+dp/dt), recover CF, and reduce myocardial infarct size, respectively. Moreover, the activities of LPAATβ, 11β-HSD1, PTEN and SHP-2 were repressed by pretreatment with luteolin, kaempferol and luteoloside. CONCLUSION Luteolin, kaempferol and luteoloside show the cardioprotective effects on MIRI of isolated rat heart by against lipid metabolism disorders and apoptosis.

     

  • loading
  • [1]
    HEUSCH G.Critical issues for the translation of cardioprotection[J].Circ Res,2017,120(9):1477-1486.
    [2]
    HEUSCH G.Cardioprotection research must leave its comfort zone[J].Eur Heart J,2018,39(36):3393-3395.
    [3]
    吴楠,张晓雯.高脂血症对心肌缺血再灌注损伤的影响[J].解剖科学进展,2019,25(6):724-726,730.
    [4]
    FERDINANDY P,HAUSENLOY DJ,HEUSCH G,et al.Interaction of risk factors,comorbidities,and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning,postconditioning,and remote conditioning[J].Pharmacol Rev,2014,66(4):1142-1174.
    [5]
    PEREIRA CD,AZEVEDO I,MONTEIRO R,et al.11β-Hydroxysteroid dehydrogenase type 1:Relevance of its modulation in the pathophysiology of obesity,the metabolic syndrome and type 2 diabetes mellitus[J].Diabetes Obes Metab,2012,14(10):869-881.
    [6]
    ZHUKOVSKY MA,FILOGRANA A,LUINI A,et al.The structure and function of acylglycerophosphate acyltransferase 4/ lysophosphatidic acid acyltransferase delta (AGPAT4/LPAATδ)[J].Front Cell Dev Biol,2019,7:147.
    [7]
    TANG WW,YUAN J,CHEN XY,et al.Identification of a novel human lysophosphatidic acid acyltransferase,LPAAT-theta,which activates mTOR pathway[J].J Biochem Mol Biol,2006,39(5):626-635.
    [8]
    SAULNIER-BLACHE JS,GIRARD A,SIMON MF,et al.A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification[J].J Lipid Res,2000,41(12):1947-1951.
    [9]
    HIDESHIMA T,CHAUHAN D,HAYASHI T,et al.Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors,a novel class of agents,in multiple myeloma[J].Cancer Res,2003,63(23):8428-8436.
    [10]
    WU DN,PEI DS,WANG Q,et al.Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat Hippocampus[J].Neurosci Lett,2006,404(1/2):98-102.
    [11]
    MOCANU MM,YELLON DM.PTEN,the Achilles' heel of myocardial ischaemia/reperfusion injury?[J].Br J Pharmacol,2007,150(7):833-838.
    [12]
    KEYES KT,XU J,LONG B,et al.Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction[J].Am J Physiol Heart Circ Physiol,2010,298(4):H1198-H1208.
    [13]
    CHAN RJ,FENG GS.PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase[J].Blood,2007,109(3):862-867.
    [14]
    LEE SW,WON JY,LEE HY,et al.Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade[J].Mol Med,2011,17(9/10):1095-1106.
    [15]
    阿布卡德,田友清,尚靖.香青兰研究进展[J].北方药学,2011,8(2):55-57.
    [16]
    阿布力米提,艾来提,穆赫塔尔,等.香青兰中黄酮类化合物的研究[J].食品科学,2007,28(8):384-386.
    [17]
    谭梦晖,于波,谷颖敏,等.香青兰不同部位提取物对大鼠实验性高脂血症的影响[J].中国实验方剂学杂志,2011,17(21):209-213.
    [18]
    田友清,尚靖,何婷,等.基于中药血清化学及血清药理学方法探讨香青兰保护心肌细胞缺氧/复氧损伤物质基础[J].中国中药杂志,2012,37(5):620-624.
    [19]
    田友清,尚靖,阿布卡德.香青兰及其含药血清对H9c2心肌细胞三种缺氧/复氧损伤模型的影响[J].中国新药杂志,2012,21(15):1736-1739,1748.
    [20]
    李梦雯,于东升,田友清,等.木犀草素对心肌细胞物理性及化学性缺氧/复氧损伤的作用[J].中国药学杂志,2013,48(17):1257-1261.
    [21]
    YU DS,LI MW,TIAN YQ,et al.Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury[J].Life Sci,2015,122:15-25.
    [22]
    ZHOU MJ,REN HH,HAN JC,et al.Protective effects of kaempferol against myocardial ischemia/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3β[J].Oxid Med Cell Longev,2015,2015:481405.
    [23]
    STILES B,GROSZER M,WANG SY,et al.PTENless means more[J].Dev Biol,2004,273(2):175-184.
    [24]
    黄定德,陈杞,韩玲,等.γ线诱发的白血病小鼠胸腺细胞中SHP-2表达及功能的研究[J].第三军医大学学报,2004,26(14):1258-1260.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (522) PDF downloads(392) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return